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Abstract       
Introduction: Blood derived products have been known as an effective treatment for many 
years. However, this treatment is not without risk of infections transmission including 
hepatitis B virus (HBV) and hepatitis C virus (HCV) and human immune-deficiency virus 
(HIV) in people who received the blood. Nevertheless, due to a high risk of blood born 
diseases through blood transfusion, screening for these viruses according to the World Health 
Organization (WHO) is mandatory. The main aim of this research was to assess the 
prevalence of HBV, HCV and HIV infections among healthy blood donors of Blood Donor 
Center of Ilam (BDCI).  
Materials and methods: In this study we used the information from first and repeated blood 
donors who referred to BDCI within February 2009 to January 2013. Demographic 
characteristics of donors including marital status, age, gender and blood donation pattern was 
extracted. Routine donor laboratory screening tests for HBV, HIV and HCV were performed. 
Results: HBV infection had the highest prevalence (0.14%) while HIV had the lowest ones 
(0.006%). The highest prevalence was among male blood donors. The prevalence of HBv, 
HIV and HCV infections were more common among men and first time donors (P < 0.01). 
The prevalence of  HIV and HCV infections were more common among married donors than 
singe ones (P < 0.01) HBV prevalence in singles was more (P < 0.05) compared to married 
blood donors. The highest and the lowest subjects with HBV, HCV and HIV infections were 
in range of 51 to 60 years and 18-35 years old, respectively. 
Conclusion: It is estimated that the prevalence of HBV, HCV and HIV infections are low in 
voluntary blood donors than general population which confirmed the effectiveness of 
education and examination of blood donors. This usually arising from the pre donation 
screening for risky behaviors, so deleting the high risk people. Since unsafe blood products 
are not used for blood transfusion, they are not considered as risk for blood safety system, but 
identification of these blood units is a problem for blood transfusion centers.  
Keywords: Blood donor, Ilam City, Hepatitis B virus, Hepatitis C virus, HIV 
Introduction 
Blood derived components such as packed 
red blood cell, fresh frozen plasma (FFP) 
and cryoprecipitate have known as suitable 
therapeutic choices for long time. 
Although these blood components are 
potentially useful for a considerable 
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numbers of disorders but their potential 
risks cannot be overlook. One of the most 
common and serious complications of 
transfusion medicine.  
Viral diseases could be transmitted 
through blood donation are including 
human immune-deficiency virus (HIV), 
hepatitis C virus (HCV) and hepatitis B 
virus (HBV) (1). Hepatitis is a deadly 
disease which causes high rate of 
morbidity and mortality in the world. 
Chronic HBV and HCV infections 
accounts for the main cause of 
hepatocellular carcinoma. In the world, 
nearly 240 and 150 million people suffered 
from the HBV and HCV infections, 
respectively (2). HIV is also one of the 
worst pandemics in human history so that 
has killed 39 million people up to now and 
infected 70 million people(3). 
Nevertheless, due to the high risk of 
diseases transmission through blood 
transfusion, according to instruction of 
World Health Organization (WH O) 
screening of blood products for viral 
infections is mandatory(4). 
All donated bloods are screened in Blood 
Donor Center of Ilam (BDCI) where has 
validated by Iran Association of Blood 
Banks. In this regard, BTCI carries out 
pre-donation donor screening program 
which is designed for exclusion of 
potential donors that are in exposure to 
infectious diseases. Examples of these are 
high-risk blood donors with a history of 
transmissible infectious diseases (such as 
syphilis) and whom with high-risk 
behaviors (e.g., drug abuse by injection) 
(2). 
The main aim of this research was to 
assess the prevalence of HBV, HCV and 
HIV infections among healthy voluntary 
blood donors in the BDCI. 
Materials and methods 
Subjects and sampling. For this cross-
sectional study, medical files of donors in 
BDCI were used. All medical files of 
72527 blood donors were searched during 
the study period (February 2009 to January 
2013). Accordingly, blood donors were 
divided in two groups of regular and first-
time donors.The information was extracted 
including demographic characteristics of 
donors, level of education, marital status, 
age, gender and blood donation pattern. 
Laboratory screening tests for blood 
donation carried out according to standard 
programs at BDCI. These are including the 
most current screening test versions for 
HBC, antibody to HCV and HIV. 
Screening tests for these viral infections 
were performed by Behring Kit 
(Germany). Confirmatory test for HCV-Ab 
was done by RIBA and for HIV diagnosis 
by western blotting test. Ethical 
Committee instructions of Ilam University 
of Medical Sciences established the 
research protocol. 
Statistical analysis 
Results were reported as mean ± standard 
deviation (SD) for quantitative variables 
and percentages for categorical variables. 
Statistical significance was based on two-
sided design-based tests evaluated at the 
0.05 level of significance. All the 
statistical analyses were performed by 
SPSS software. 
Results 
A total of 72,527 volunteer blood donors 
referring to the Blood Transfusion 
Organization of Ilam City, Iran were 
assessed. The average annual number of 
blood donors was 14,000 cases. From the 
total number, 134 people were infected by 
infectious diseases. Out of 134, 102 cases 
(76.1%) were HBS-Ag positive, 27 cases 
(20.14%) HCV positive and 5 cases 
(3.75%) were positive for each of HCV-
Ag and HIV-Ab, respectively (Figure 1). 
Briefly, HBS had the highest prevalence 
(0.14%) while HIV had lowest ones 
(0.006%). The prevalence of HBS, HIV 
and HCV in male sex was more than the 
female (P < 0.01). Above mentioned viral 
diseases was more in first time donors than 
the repeated ones (P < 0.01) (Table 1). The 
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number of married blood donors with HIV 
and HCV (P < 0.01) was more than single 
donors. HBS in single donors was more 
and significant (P < 0.05). The highest and 
the lowest subjects with HBS, HCV and 
HIV were in the ranges of 51 to 60 years 
and 18-35 years, respectively. 
The seroconversion rates among first time 
versus repeated donors were for HBS-Ag 
positive 0.12% vs. 0.0008%, followed by 
HCV-Ag positive 0.12% vs. 0.01%, HIV-
Ab positive 0.13% vs. 0%.
 
Figure 1. The prevalence rate of volunteer blood donor with HIV-Ab, HCV-Ag and HBsAg positive referred to 
the BDCI for the period February 2009 to January 2013.  
Discussion  
This research is the largest 
epidemiological study to determine the 
prevalence of HBV, HCV and HIV among 
healthy voluntary blood donors in Ilam 
City and no study has been published in 
this field. Actual prevalence of blood born 
disease may be underestimated mostly due 
to present of screening program in blood 
transfusion center for risky behaviors 
before blood donation and low degree of 
self-selection as well as elimination of 
high-risk donors (2). 
However, contaminated blood products 
with viral infections are not used for blood 
transfusion, they are not considered a risk 
for blood transfusion centers but 
identification of these contaminated blood 
unites is a problem for blood transfusion 
centers (1). Accurate assessments of 
transfusion-transmitted disease should be 
performed for infectious bloods donate in 
the time period between the arrival time of 
disease and diagnosis. 
According to our study the prevalence 
rates of HIV, HCV and HBV are less in 
people who donated bloods repeated than 
first time ones. The seroconversion rates 
among first time versus repeated donors 
were for HBS-Ag positive 0.12% vs. 
0.0008%, followed by HCV-Ag positive 
0.12% vs. 0.01%, HIV-Ab positive 0.13% 
vs. 0%. Majdzadeh et al. have revealed 
that the prevalence of HBS-Ag positive in 
voluntary donors was 0.8% while it was 
1.7% in general population (5). In the 
study of Bastiaans et al. and Glynn et al., 
HBV prevalence was 0.26% and 0.2% 
respectively among first-time volunteer 
blood donors at American blood service 
centers in the US (6-9). Studies have 
shown that the HBV prevalence in Asians 
populations has decreased over the years 
from 2006 to 2010. But, the proportion of 
total HBV positive people remained 
relatively constant among all first-time 
blood donors. The 0.0008% prevalence of 
HBV among repeated blood donors may 
D
ow
nl
oa
de
d 
fro
m
 jb
rm
s.m
ed
ila
m.
ac
.ir 
at 
9:4
3 I
RS
T o
n T
ue
sd
ay
 D
ec
em
be
r 5
th 
20
17
    
    
  [ 
DO
I: 1
0.1
88
69
/ac
ad
pu
b.j
brm
s.4
.2.
4 ]
  
Original article                                                                   J Bas Res Med Sci 2017; 4(2):4-8 . 
7 
 
be due to the missed cases during previous 
donations or might have infected with a 
new infection (2). Similar to our research, 
an estimated 0.23% of HCV prevalence 
among first-time blood donors was noted 
in a large cross-sectional research from six 
US blood donor centers during 2006 to 
2007. The highest prevalence was reported 
among males and older age donor subjects. 
There are lower HCV prevalence (0.01%) 
among repeated blood donors because they 
tend to have less risk-prone behavior (10). 
The prevalence of Hepatitis C from blood 
donors in several searches changed 
considerably in Iran, depend on the 
number of participants and period of study, 
sample sizes, geographical region and etc 
(11, 12). A study reported that the 
prevalence of hepatitis C among 10739221 
of blood donors was 0.5% during six years 
from 1996 to 2011(8). In another report, 
the prevalence of hepatitis C amongst 
more than six million blood donors was 
0.13% from 2004 to 2007 (13). 
Some research have exhibited that the 
prevalence of HCV-Ag positive in blood 
donors is less than 1% (14). Since that 
there is no exact estimation of AIDS in 
Iran, nevertheless according to news 
reports it is nearly 0.12 % (15). Since the 
prevalence of viral infections among blood 
donors is less than general population, it 
revealed effectiveness of educational 
programs of blood donors as well as taking 
of clinical history. 
In this study, the prevalence of hepatitis B, 
C and HIV was more among first time 
blood donors than repeated ones. It may be 
due to refuse of risky behaviors among 
repeated donors or more willing to blood 
donation to assess of them health. Because 
regular blood donors have had previous 
donation screening test with negative 
results and been trained about high-risk 
behaviors, going possibility of them to the 
high-risk behaviors must be lower and 
their blood safety is more (1). 
In our work, other factors were considered 
including the prevalence rate with compare 
to sex of blood donors.  Males had higher 
prevalence of HIB, HIV and HCV 
infections than females. Men are more 
likely to acquire infection because they are 
prone to risky behaviors (2). According to 
results of this study, the total prevalence of 
hepatitis B, and HIV has diminished over 
the years, may be due to the better 
screening methods. However, the 
prevalence rate of hepatitis C shows a 
slight increase during the years 2011 to 
2013 (data not shown). The reason of this 
matter must be considered in another study 
Conclusion 
Due to a high risk of diseases transmission 
through blood donation, screening for 
these viruses is mandatory according to the 
World Health Organization (WHO). 
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